Propylene Glycol

Propylene Glycol

SCHEMBL602325

CC(=O)CCC(=O)OC(C)C.CC(O)CO

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Propylene Glycol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TSHR P16473 4/20 0.39
MAPT P10636 2/20 0.38
MAPK1 P28482 1/20 0.35
SLC15A2 Q16348 1/20 0.34
NOTUM Q6P988 1/20 0.34
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PRKCA P17252 1/20 0.31
PRKCE Q02156 1/20 0.31
PRKCQ Q04759 1/20 0.31
PRKCD Q05655 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isopropyl Alcohol SCHEMBL811815 0.90 LMNA (0.50) LMNATDP1ALDH1A1TSHRMAPT
SCHEMBL811107 0.89 LMNA (0.54) LMNATDP1ALDH1A1TSHRMAPT
SCHEMBL11816713 0.87 LMNA (0.52) LMNATDP1ALDH1A1TSHRMAPT
SCHEMBL6578392 0.82 LMNA (0.53) LMNAALDH1A1TSHRMAPTMAPK1
Propylene Glycol SCHEMBL18393442 0.82 TSHR (0.54) LMNATDP1ALDH1A1TSHRMAPT
Hexane SCHEMBL8012017 0.80 LMNA (0.71) LMNAALDH1A1TSHRMAPTMAPK1
SCHEMBL72471 0.80 LMNA (0.62) LMNAALDH1A1TSHRMAPTNOTUM
SCHEMBL1896624 0.79 ALDH1A1 (0.43) LMNATDP1ALDH1A1TSHRMAPT
SCHEMBL4567081 0.79 ALDH1A1 (0.43) LMNATDP1ALDH1A1TSHRMAPT
SCHEMBL1898675 0.79 ALDH1A1 (0.43) LMNATDP1ALDH1A1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2925738-B1 CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF GFBIOCHEMICALS LTD (MT) 2018-01-10 EP disclosed
US-9156809-B2 Carboxy ester ketals, methods of manufacture, and uses thereof SEGETIS, INC. (US) 2015-10-13 US disclosed
EP-2603565-B1 LATEX COATING COMPOSITIONS INCLUDING CARBOXY ESTER KETAL COALESCENTS, METHODS OF MANUFACTURE, AND USES THEREOF SEGETIS INC (US) 2015-10-07 EP disclosed
EP-2925738-A1 CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF Segetis, Inc. (US) 2015-10-07 EP disclosed
US-9074065-B2 Latex coating compositions including carboxy ester ketal coalescents, methods of manufacture, and uses thereof SEGETIS, INC. (US) 2015-07-07 US disclosed
WO-2014085609-A1 CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF SEGETIS, INC. (US) 2014-06-05 WO disclosed
US-20140147395-A1 CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF SEGETIS, INC. (US) 2014-05-29 US disclosed
CN-103052691-B Latex coating compositions including carboxy ester ketal coalescents, methods of manufacture, and uses thereof SEGETIS INC 2014-05-28 CN disclosed
EP-2603565-A2 LATEX COATING COMPOSITIONS INCLUDING CARBOXY ESTER KETAL COALESCENTS, METHODS OF MANUFACTURE, AND USES THEREOF Segetis, Inc. (US) 2013-06-19 EP disclosed
CN-103052691-A Latex coating compositions including carboxy ester ketal coalescents, methods of manufacture, and uses thereof SEGETIS INC 2013-04-17 CN disclosed
WO-2012021826-A2 LATEX COATING COMPOSITIONS INCLUDING CARBOXY ESTER KETAL COALESCENTS, METHODS OF MANUFACTURE, AND USES THEREOF SEGETIS, INC. (US) 2012-02-16 WO disclosed
US-20120041110-A1 LATEX COATING COMPOSITIONS INCLUDING CARBOXY ESTER KETAL COALESCENTS, METHODS OF MANUFACTURE, AND USES THEROF SEGETIS, INC. (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140147395-A1 CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF C9, C5, C1S LMNA 2576/4885TDP1 2702/4885ALDH1A1 769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.